Latest posts tagged with #NAMs on Bluesky
🧪 If your institution has multidisciplinary collaborative research spaces, core labs, or state-of-the-art facilities that support emerging #NAMs or human-based research technologies, this one is for you!
❌ Facilities focused on supporting animal research or animal care are not eligible to apply.
On the anniversary of the #EU ban on #AnimalTesting for #cosmetics, Monique Sundin explains how animal testing was replaced, how the ban was implemented and clarifies the limited exceptions and the reasons behind them. www.youtube.com/watch?v=d-qw...
#CosmeticsBan #EURegulation #NAMs #SciencePolicy
How does this impact #AnimalMethodsBias?
When review labor is stretched thin, expertise gaps grow. But appropriate expertise is crucial to ensure that #NAMs studies receive high-quality reviews and that animal-based studies aren’t unfairly favored.
#BaCell3D #3DCellBiology #Organoids #InVitroModels #StemCells #3R #Bioengineering #NAMs #Networking #Collaboration #DiseaseModeling #NonAnimalModels #InVitro #Organoid #OoC #OrganOnChip #NewApproachMethodologies #MPS #MicrophysiologicalSystems #Assembloids #Tumoroids #LifeSciences#BiomedicalResearch
#BaCell3D #3DCellBiology #Organoids #InVitroModels #StemCells #3R #Bioengineering #NAMs #Networking #Collaboration #DiseaseModeling #NonAnimalModels #InVitro #Organoid #OoC #OrganOnChip #NewApproachMethodologies #MPS#MicrophysiologicalSystems #Assembloids #Tumoroids #LifeSciences #BiomedicalResearch
We hear this often.
Innovative, animal‑free research gets slowed by expectations that animal data are required for a study to be considered “complete.”
This #AnimalMethodsBias shapes peer review, funding decisions, and publication.
It's a major barrier blocking the wider adoption of #NAMs.
Where are we heading with animal research and NAMs?
Last week I was back at NOVA Medical School for The #3Rs Framework for Intelligent Use of In Vitro, In Vivo, and #NAMs in Lisbon.
I spoke about communicating why animal research and NAMs need to work hand in hand.
1/2
"The age of animal experiments is waning," writes @dianakwon.bsky.social for @nature.com
www.nature.com/articles/d41...
Kwon covers the recent policy changes in the U.S. & U.K. that give major boosts to the use & development of non-animal methodologies.
#NAMs #SciPol 🧪
🔬 New study (Mizuno et al., 2026) combining alvaDesc molecular descriptors with mechanism-based in vitro assays to improve read-across prediction of rat thyroid carcinogenicity.
📖 Paper: doi.org/10.1016/j.fc...
🔗 alvaDesc: alvascience.com/alvadesc/
#alvaDesc #ReadAcross #QSAR #NAMs #chemsky
🎉 Bronze Sponsor: PyroScience GmbH! 🎉 We’re excited to welcome PyroScience GmbH at THE 3R LÄND Conference 2026! Their state‑of‑the‑art sensors and technologies are advancing a wide range of applications — contributing to innovative #NAMs and human‑relevant research.
Read the full paper by Ramak Khosravi and Milica Radisic of @uhn.ca, @dukesurgery.bsky.social, and @bme-uoft.bsky.social and @donnellycentre.bsky.social at @utoronto.ca.
www.nature.com/articles/s41...
Supported by CHIR, NHLBI, NSERC, @innovation.ca, and SVRF.
#CardioSky #NAMs #Microfluidics
Super elated to share our preprint on a new #PlacentaOnChip model that is 1) Scalable, 2) Microfluidics-free & 3) High-throughput capable
Proud of the hard work by Anshul and Sourav done in collab with Abhijit at IITB
#organonchip #NAMS
biorxiv.org/content/10.648…www.biorxiv.org/content/10.6...v1
We are proud to announc the launch of VISI-ON-BRAIN, a €4.5M #HorizonEurope #MSCA Doctoral Network coordinated by @Creatio
15 early-stage researchers will develop human #inVitro & #inSilico #NAMs beyond animal models.
👉 bit.ly/VISI-ON-BRAIN
@ub.edu @idibaps.bsky.social @ubneuro.bsky.social
#organoids #organ-on-chip #myeloma #NAMs #myeloma @imm.ox.ac.uk
This year, we also saw real momentum for non‑animal, human‑relevant science. SAO’s Gabby Vidaurre, PhD gave a standout Postdoc Talk on Research Modernization NOW, and AI‑driven breakthroughs—from lung‑ultrasound to exposome analytics—took center stage.
#scipol #sciencepolicy #NAMs #AI
New law review article by @amandaelyse.bsky.social of @seattleulaw.bsky.social on why it makes absolutely no sense to use animals for preclinical #psychedelic research.
🐭🍄
🥼 It's already done in humans!
✅ Long history of safety
⚖️ Harm w/o scientific benefit
🧍 Policy shifts toward #NAMs
Graphic announcing a presentation at the AAAS Annual Meeting, Science @ Scale. Along with a photo of Gabby Vidaurre, PhD is the following text: "Science without animals: a scalable policy vision for the public good. Gabby Vidaurre, Ph.D., Feb 14, 2026. 2:30 - 3:30. Expo Stage."
📣 Attending #AAASmtg? Make sure to add this talk by SAO's Gabby Vidaurre, PhD to your Saturday schedule.
As global & U.S. initiatives accelerate toward #NAMs, Dr. Vidaurre will unpack the scientific & policy landscape driving this shift & what still needs to be pushed forward.
@aaas.org #AAAS2026
ICYMI 🧪 For @snexplores.bsky.social, Avery Hurt broke down how AI, organs-on-a-chip, and other human-based models are delivering better research at lower cost and in less time.
Feat. experts from @jhucaat.bsky.social, @harvardmed.bsky.social, & NIH.
www.snexplores.org/article/rese...
#NAMs
#organoids #stemcells #invitromodels #NAMs #3R #3DBiology #CellCulture #TissueEngineering #DiseaseModeling #DrugDiscovery #Bioengineering #InVitro #RegenerativeMedicine
We’re proud to share that MIMETAS is a founding member of IAMPS, the world’s first industry alliance dedicated to advancing microphysiological systems (MPS).
With 8 other European innovators, IAMPS will accelerate regulatory acceptance, standardization & adoption of #NAMs. shorturl.at/dLRcF
#RISK-HUNT3R #GeneralAssembly was inspiring!
🚀 #ASPIS training ("How to assemble a case study for NGRA"), #Innovation #Radar, #OECD #IATA #casestudies & project #progress. Great feedback from SRAB & PIs!
See you at the project final event in Autumn 2026!
#NAMs #ASPA #ECroadmap #Sustainability #H2020
How does SAO define #NAMs?
Find out in this blog by Gabby Vidaurre, PhD: www.scienceadvancement.org/reflections/...
Collaboration works a lot better when we’re all speaking the same language. 🤝 ✨
#biomedicalresearch #sciencecommunication #scicomm
A tan, brown, and crimson graphic with icons representing stacked papers and bullseyes with dollar figure targets. The title reads: “NAMs-Relevant Highlighted Topics” and includes a list of six research area topics. “Find more at: grants.nih.gov/funding/find-a-fit-for-your-research/highlighted-topics.”
U.S. researchers: Don't forget to check NIH's Highlighted Topics page when considering your next grant application! grants.nih.gov/funding/find...
Recent topics of interest to #NAMs researchers are listed in the graphic.
#NIH #NIHfunding 🧪
👥 Diversifying review groups to boost inclusion of #NAMs expertise—this can avoid potential reviewer preferences for animal-based methods and ensure that NAM-based proposals are adequately evaluated for rigor and model suitability
⬇️
The International Collaboration on Cosmetics Safety (ICCS) has announced the election of its 2026 Board officers.
#BeautyIndustryNews #BusinessofBeauty #CosmeticSafety #NAMs
buff.ly/hWZJka8
Regulators and funders are pushing more R&D into human-relevant in vitro systems.
Oxygen control is becoming baseline lab infrastructure.
New article from Life Science Daily News (by Justin Croft):
lifesciencedaily.news/why-hypoxia-...
#cellculture #hypoxia #reproducibility #organoids #NAMs
In it, we discuss:
⚖️ How #PeerReview bias can tilt the scales against #NAMs in grant & manuscript reviews.
🌎 How new US/UK initiatives may help reduce this bias (they’re a great start!).
🎯 What else is needed to address animal methods bias as the world moves away from animal experimentation
🐟 🧫 What if #NAMs worked better together?
Combining #organoids, #zebrafish embryos, and in silico models, and supporting them with automation, strengthens insight, reduces variability, and builds trust in complex data, enabling more ethical and human-relevant models.
Read how 👉 zurl.co/BavDF
🤝 New partnership: AsedaSciences + Xenometrix
We’re integrating the Ames mutagenicity test into the 3RnD® platform—modernizing a regulatory-trusted assay to support earlier, NAM-based genotox decisions at scale.
Learn more: lnkd.in/e7DwHEBF
@scicrunch.bsky.social #Biotech #Genotoxicity #NAMs
